Definitive Healthcare Corp. (DH) vs Immunic, Inc. (IMUX)
A side-by-side comparison of Definitive Healthcare Corp. and Immunic, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DH
Definitive Healthcare Corp.
$1.00HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
IMUX
Immunic, Inc.
$7.88HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
Total return — DH vs IMUX
growth of $100 · dividends reinvested · last 5yDH -97.7% (-53.1%/yr)IMUX -91.7% (-39.2%/yr)IMUX compounded faster over this window
DH IMUX
DH vs IMUX: by the numbers
- •IMUX is the larger company ($107M vs $105M market cap).
- •Both run net losses; IMUX's is the smaller (0.00% vs -72.28% net margin).
Metrics side by side
Valuation
| Metric | DH | IMUX |
|---|---|---|
| Forward P/E | 5.13 | N/A |
| P/S ratio | 0.45 | N/A |
| P/B ratio | 0.73 | 0.84 |
| EV / EBITDA | 0.49 | N/A |
| FCF yield | 27.12% | N/A |
Profitability
| Metric | DH | IMUX |
|---|---|---|
| Gross margin | 71.67% | 0.00% |
| Operating margin | -8.52% | 0.00% |
| Net margin | -72.28% | 0.00% |
| ROE | -116.28% | -87.45% |
| ROIC | 41.64% | -92.16% |
Growth (annualized)
| Metric | DH | IMUX |
|---|---|---|
| Revenue CAGR (5Y) | 10.62% | N/A |
| FCF CAGR (5Y) | 2.14% | N/A |
| Total return CAGR (5Y) | -52.54% | -35.70% |
Frequently asked
- How have DH and IMUX total returns compared?
- Over the past 5 years, DH delivered -52.54% and IMUX delivered -35.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Definitive Healthcare ROEImmunic ROEDefinitive Healthcare operating marginImmunic operating marginDefinitive Healthcare revenue growthImmunic revenue growthDefinitive Healthcare free cash flowImmunic free cash flow
Definitive Healthcare & Immunic appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.